Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer

Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer

Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains incompletely understood. Retrospective analysis of NSCLC patien...

Popoln opis

Bibliografske podrobnosti
Main Authors: Jonathan N. Le, Jordan O. Gasho, Olivia Peony, Asneh Singh, Katrina D. Silos, Sungjin Kim, Anthony T. Nguyen, Mitchell Kamrava, Amin Mirhadi, Behrooz Hakimian, Karen L. Reckamp, Kamya Sankar, Raymond H. Mak, Andriana P. Nikolova, Katelyn M. Atkins
Format: Article
Jezik:English
Izdano: Frontiers Media S.A. 2024-12-01
Serija:Frontiers in Cardiovascular Medicine
Teme:
osimertinib
lung cancer
cardiac toxicity
echocardiogram
EGFR
Online dostop:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1485033/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1485033/full

Podobne knjige/članki